Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer

29 Jun 2023

Abstract excerpt

Background: Gastric cancer (GC) is one of the most prevalent cancers, and it has unsatisfactory overall treatment outcomes. DNA damage repair (DDR) is a complicated process for signal transduction that causes cancer. lncRNAs can influence the formation and incidence of cancers by influencing DDR-related mRNAs/miRNAs. A DDR-related lncRNA prognostic model is urgently needed to improve treatment strategies....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37457685
DOI: 10.3389/fimmu.2023.1117255

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancerPMID 37457685Read ↗

Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response GenesSemantic proximity Read ↗

Novel DNA damage repair signature for immunotherapy and a proposed molecular subtyping scheme in gastric cancerSemantic proximity Read ↗

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerSemantic proximity Read ↗

Efferocytosis-Related LncRNA Signatures for Predicting Prognosis and Immune Landscape of Gastric CancerSemantic proximity Read ↗

Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric CancerSemantic proximity Read ↗

Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancerSemantic proximity Read ↗

A novel prognostic risk model construction and immune landscape analysis of gastric cancer based on disulfidptosis-related lncRNAsSemantic proximity Read ↗

Analysis and Prognosis of Tumor Immune Infiltrates and Immune Microenvironment of m6A-Related LncRNAs in Patients with Gastric CancerSemantic proximity Read ↗

Identification and validation of a novel redox- related differentially expressed lncRNA prognostic signature for predicting clinical immunotherapy response in gastric cancerSemantic proximity Read ↗

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAsSemantic proximity Read ↗

Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencingSemantic proximity Read ↗

Identification of lysosome-related genes in gastric cancer and development of a prognostic modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.